Insider Trading activities of Incyte Corp insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Incyte Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Incyte Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Incyte Corp since 2005. The reporting company's ticker symbol is INCY. The reporting company's CIK number is 879169.
The total value of stock buying since 2005 is $313,711,766.
The total value of stock sales since 2005 is $507,775,898.
The total value of stock option exercises since 2005 is $88,892,729.


 1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Incyte Corp insiders (INCY) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-05-06 Levy Richard S (EVP, Chief Drug Dev Officer) Sale 7,412 99.43 736,975
2015-05-06 Levy Richard S (EVP, Chief Drug Dev Officer) Option Ex 7,412 18.32 135,787
2015-04-23 Daly James M (EVP, Chief Commercial Officer) Sale 36,941 107.67 3,977,437
2015-04-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 36,941 29.03 1,072,323
2015-04-17 Wenqing Yao (EVP, Discovery Medicinal and P) Sale 7,150 102.04 729,586
2015-04-16 Huber Reid M (EVP, Chief Scientific Officer) Option Ex 10,060 15.28 153,746
2015-04-14 Siegel Eric H. (EVP, General Counsel) Sale 2,222 98.72 219,355
2015-04-14 Siegel Eric H. (EVP, General Counsel) Option Ex 2,222 18.32 40,707
2015-04-13 Wenqing Yao (EVP, Discovery Medicinal and P) Sale 14,000 96.75 1,354,500
2015-04-13 Wenqing Yao (EVP, Discovery Medicinal and P) Option Ex 14,000 17.79 249,060
2015-04-13 Swain Paula J (EVP, Human Resources) Sale 16,469 96.29 1,585,800
2015-04-13 Swain Paula J (EVP, Human Resources) Option Ex 16,469 3.11 51,218
2015-04-10 Wenqing Yao (EVP, Discovery Medicinal and P) Sale 9,000 92.75 834,750
2015-04-10 Wenqing Yao (EVP, Discovery Medicinal and P) Option Ex 9,000 17.79 160,110
2015-04-07 Wenqing Yao (EVP, Discovery Medicinal and P) Sale 20,031 90.16 1,805,914
2015-04-07 Wenqing Yao (EVP, Discovery Medicinal and P) Option Ex 5,000 17.79 88,950
2015-04-06 Levy Richard S (EVP, Chief Drug Dev Officer) Sale 25,000 88.77 2,219,250
2015-04-06 Levy Richard S (EVP, Chief Drug Dev Officer) Option Ex 25,000 18.32 458,000
2015-03-30 Huber Reid M (EVP, Chief Scientific Officer) Sale 34,263 93.67 3,209,483
2015-03-30 Huber Reid M (EVP, Chief Scientific Officer) Option Ex 34,263 18.05 618,618
2015-03-30 Chardonnet Laurent (Other) Sale 113,776 93.64 10,653,984
2015-03-30 Chardonnet Laurent (Other) Option Ex 113,776 16.04 1,825,308
2015-03-16 Swain Paula J (EVP, Human Resources) Sale 17,500 89.97 1,574,475
2015-03-16 Swain Paula J (EVP, Human Resources) Option Ex 17,500 3.11 54,425
2015-03-12 Siegel Eric H. (EVP, General Counsel) Sale 2,222 89.72 199,346
2015-03-12 Siegel Eric H. (EVP, General Counsel) Option Ex 2,222 18.32 40,707
2015-03-12 Ariko Barry A (Director) Sale 80,000 89.27 7,141,600
2015-03-12 Ariko Barry A (Director) Option Ex 80,000 5.96 476,800
2015-03-10 Wenqing Yao (EVP, Discovery Medicinal and P) Option Ex 4,404 18.05 79,514
2015-03-06 Levy Richard S (EVP, Chief Drug Dev Officer) Sale 25,000 89.91 2,247,750
2015-03-06 Levy Richard S (EVP, Chief Drug Dev Officer) Option Ex 25,000 18.32 458,000
2015-03-05 Siegel Eric H. (EVP, General Counsel) Sale 13,333 90.00 1,199,970
2015-03-05 Siegel Eric H. (EVP, General Counsel) Option Ex 13,333 18.32 244,260
2015-03-05 De Schutter Richard U (Director) Sale 40,000 91.94 3,677,400
2015-03-05 De Schutter Richard U (Director) Option Ex 40,000 17.09 683,720
2015-02-25 Siegel Eric H. (EVP, General Counsel) Sale 13,333 85.00 1,133,305
2015-02-25 Siegel Eric H. (EVP, General Counsel) Option Ex 13,333 18.32 244,260
2015-02-24 Daly James M (EVP, Chief Commercial Officer) Sale 8,334 81.77 681,471
2015-02-24 Daly James M (EVP, Chief Commercial Officer) Option Ex 8,334 16.62 138,511
2015-02-23 Daly James M (EVP, Chief Commercial Officer) Sale 2,778 83.44 231,796
2015-02-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 2,778 18.32 50,892
2015-02-18 Ariko Barry A (Director) Sale 20,000 78.43 1,568,600
2015-02-18 Ariko Barry A (Director) Option Ex 20,000 7.68 153,600
2015-02-17 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 12,000 76.90 922,800
2015-02-17 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 12,000 16.25 195,060
2015-02-17 Swain Paula J (EVP, Human Resources) Sale 17,500 76.90 1,345,750
2015-02-17 Swain Paula J (EVP, Human Resources) Option Ex 17,500 3.11 54,425
2015-02-13 Friedman Paul A (Director) Sale 120,000 74.32 8,918,400
2015-02-06 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 25,000 75.11 1,877,750
2015-02-06 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 25,000 18.32 458,000
2015-01-26 Siegel Eric H. (EVP, General Counsel) Sale 1,042 80.00 83,360
2015-01-26 Siegel Eric H. (EVP, General Counsel) Option Ex 1,042 17.79 18,537
2015-01-23 Daly James M (EVP, Chief Commercial Officer) Sale 11,109 77.68 862,947
2015-01-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 11,109 17.19 190,930
2015-01-23 Siegel Eric H. (EVP, General Counsel) Sale 11,458 80.00 916,640
2015-01-23 Siegel Eric H. (EVP, General Counsel) Option Ex 11,458 17.79 203,837
2015-01-22 Siegel Eric H. (EVP, General Counsel) Sale 1,042 77.99 81,265
2015-01-22 Siegel Eric H. (EVP, General Counsel) Option Ex 1,042 17.79 18,537
2015-01-20 Swain Paula J (EVP, Human Resources) Sale 17,500 74.17 1,297,975
2015-01-20 Swain Paula J (EVP, Human Resources) Option Ex 17,500 3.11 54,425
2015-01-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 12,000 73.07 876,839
2015-01-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 12,000 14.72 176,640
2015-01-08 Siegel Eric H. (EVP, General Counsel) Sale 15,626 75.00 1,171,950
2015-01-08 Siegel Eric H. (EVP, General Counsel) Option Ex 15,626 16.53 258,250
2015-01-06 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 25,000 71.84 1,796,000
2015-01-06 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 25,000 18.32 458,000
2015-01-05 Swain Paula J (EVP, Human Resources) Sale 17,500 73.90 1,293,250
2015-01-05 Swain Paula J (EVP, Human Resources) Option Ex 17,500 3.11 54,425
2014-12-23 Daly James M (EVP, Chief Commercial Officer) Sale 11,113 74.43 827,140
2014-12-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 11,113 17.19 190,999
2014-12-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 12,000 72.36 868,320
2014-12-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 12,000 14.72 176,640
2014-12-02 Huber Reid M (EVP, Chief Scientific Officer) Option Ex 6,494 9.41 61,108
2014-12-02 De Schutter Richard U (Director) Sale 47,800 74.87 3,578,786
2014-12-01 De Schutter Richard U (Director) Sale 2,200 75.26 165,572
2014-11-24 Daly James M (EVP, Chief Commercial Officer) Sale 11,111 74.08 823,102
2014-11-24 Daly James M (EVP, Chief Commercial Officer) Option Ex 11,111 17.19 190,964
2014-11-17 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 12,000 69.97 839,640
2014-11-17 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 12,000 14.72 176,640
2014-11-12 Huber Reid M (EVP, Chief Scientific Officer) Option Ex 17,960 5.99 107,634
2014-11-06 Friedman Paul A (Director) Sale 185,653 67.87 12,600,269
2014-11-06 Friedman Paul A (Director) Option Ex 185,653 11.38 2,111,802
2014-10-23 Daly James M (EVP, Chief Commercial Officer) Sale 11,111 53.49 594,327
2014-10-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 11,111 17.19 190,964
2014-10-23 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 13,904 3.11 43,241
2014-10-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 8,000 49.03 392,240
2014-10-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 8,000 14.72 117,760
2014-09-23 Daly James M (EVP, Chief Commercial Officer) Sale 11,111 47.65 529,439
2014-09-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 11,111 17.19 190,964
2014-09-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 8,000 47.58 380,640
2014-09-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 8,000 14.72 117,760
2014-08-25 Daly James M (EVP, Chief Commercial Officer) Sale 11,111 51.96 577,327
2014-08-25 Daly James M (EVP, Chief Commercial Officer) Option Ex 11,111 17.19 190,964
2014-08-18 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 8,000 51.97 415,760
2014-08-18 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 8,000 14.72 117,760
2014-07-23 Daly James M (EVP, Chief Commercial Officer) Sale 11,111 48.54 539,327
2014-07-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 11,111 17.19 190,964
2014-07-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 8,000 48.15 385,200
2014-07-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 8,000 14.72 117,760
2014-06-23 Daly James M (EVP, Chief Commercial Officer) Sale 11,111 56.15 623,882
2014-06-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 11,111 17.19 190,964
2014-06-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 8,000 53.88 431,040
2014-06-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 8,000 14.72 117,760
2014-06-05 Hastings David C (Chief Financial Officer) Sale 123,966 52.81 6,546,644
2014-06-05 Hastings David C (Chief Financial Officer) Option Ex 123,966 5.99 742,928
2014-06-04 Hastings David C (Chief Financial Officer) Sale 76,034 52.61 4,000,148
2014-06-04 Hastings David C (Chief Financial Officer) Option Ex 76,034 13.81 1,050,409
2014-05-23 Daly James M (EVP, Chief Commercial Officer) Sale 11,111 48.48 538,661
2014-05-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 11,111 17.19 190,964
2014-05-21 Baker Bros. Advisors (gp) Llc (Director) Option Ex 30,000 7.02 210,600
2014-05-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 8,000 50.68 405,440
2014-05-16 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 8,000 14.72 117,760
2014-05-12 Chardonnet Laurent (Other) Sale 2,058 54.00 111,132
2014-05-02 Chardonnet Laurent (Other) Sale 34,000 51.55 1,752,700
2014-05-02 Chardonnet Laurent (Other) Option Ex 34,000 9.41 319,940
2014-04-28 Brooke Paul A (Director) Option Ex 25,000 7.02 175,500
2014-04-23 Daly James M (EVP, Chief Commercial Officer) Sale 30,555 47.71 1,457,779
2014-04-23 Daly James M (EVP, Chief Commercial Officer) Option Ex 30,555 17.19 525,148
2014-02-20 Friedman Paul A (Director) Sale 33,354 63.51 2,118,312
2014-02-20 Friedman Paul A (Director) Option Ex 33,354 3.11 103,730
2014-02-19 Friedman Paul A (Director) Sale 40,919 62.66 2,563,984
2014-02-19 Friedman Paul A (Director) Option Ex 40,919 3.11 127,258
2014-02-19 De Schutter Richard U (Director) Sale 7,455 65.50 488,302
2014-02-19 De Schutter Richard U (Director) Option Ex 7,455 8.88 66,200
2014-02-18 Hastings David C (Chief Financial Officer) Sale 32,001 65.64 2,100,545
2014-02-18 Hastings David C (Chief Financial Officer) Option Ex 32,001 8.99 287,688
2014-02-18 Friedman Paul A (Director) Sale 720,036 65.82 47,392,769
2014-02-18 Friedman Paul A (Director) Option Ex 720,036 7.71 5,548,597
2014-02-18 De Schutter Richard U (Director) Sale 42,545 65.54 2,788,399
2014-02-18 De Schutter Richard U (Director) Option Ex 42,545 8.88 377,799
2014-02-14 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 39,787 66.13 2,631,114
2014-02-14 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 39,787 12.03 478,637
2014-02-14 Hastings David C (Chief Financial Officer) Sale 40,000 64.74 2,589,600
2014-02-14 Hastings David C (Chief Financial Officer) Option Ex 40,000 8.99 359,600
2014-02-14 Friedman Paul A (Director) Sale 10,227 65.52 670,073
2014-02-14 Friedman Paul A (Director) Option Ex 10,227 11.98 122,519
2014-02-13 Daly James M (EVP, Chief Commercial Officer) Sale 158,331 66.49 10,527,428
2014-02-13 Daly James M (EVP, Chief Commercial Officer) Option Ex 158,331 17.19 2,721,234
2014-02-13 Siegel Eric H. (EVP, General Counsel) Sale 56,042 66.58 3,731,556
2014-02-13 Siegel Eric H. (EVP, General Counsel) Option Ex 54,855 16.07 881,684
2014-02-13 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 191,309 66.38 12,699,091
2014-02-13 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 191,309 9.98 1,909,072
2014-02-13 Chardonnet Laurent (Other) Sale 98,334 66.28 6,517,577
2014-02-13 Chardonnet Laurent (Other) Option Ex 98,334 7.87 774,183
2014-02-13 Hastings David C (Chief Financial Officer) Sale 202,999 66.12 13,422,293
2014-02-13 Hastings David C (Chief Financial Officer) Option Ex 202,999 13.96 2,834,475
2014-02-13 Swain Paula J (EVP, Human Resources) Sale 216,967 66.73 14,478,207
2014-02-13 Swain Paula J (EVP, Human Resources) Option Ex 216,967 10.70 2,322,197
2014-02-13 Ariko Barry A (Director) Sale 10,000 66.49 664,900
2014-02-13 Ariko Barry A (Director) Option Ex 10,000 7.02 70,200
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of INCY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Incyte Corp (symbol INCY, CIK number 879169) see the Securities and Exchange Commission (SEC) website.